Treatment of EGFR mutation patients

Date 14 April 2016
Event European Lung Cancer Conference 2016 (ELCC) 2016
Session Optimizing the use of TKI in oncogene addicted NSCLC
Topics Anticancer Agents
Non-Small Cell Lung Cancer
Biological Therapy
Presenter Kenneth O'Byrne
Authors K. O'Byrne
  • Princess Alexandra Hospital, Brisbane/AU


Clinical trial identification